Answers are grounded in this paper and cite their sources.
Long-term lumasiran treatment enabled sustained lowering of UOx levels with acceptable safety and encouraging results on clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Hulton et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: